Four minor benanomicins, dexylosylbenanomicins A and B, 2'-demethylbenanomicin A and 7-methoxybenanomicinone have been isolated from the culture nitrate of Actinomadura sp. MH193-16F4. Their structures were confirmed by spectral analyses. Dexylosylbenanomicins A and B were derived chemically from benanomicins A and B, respectively.
Isolation
Antibiotics in the culture filtrate of the strain MH193-16F4were analyzed by HPLCusing a reverse-phase ion-pair column and a UVdetection method at 280nm. As shown in Fig. 1 , in addition to benanomicins A and B (Rt's 24.6 and 8.2 minutes, respectively), several minor antibiotics including dexylosylbenanomicin A, 2'-demethylbenanomicin A, dexylosylbenanomicin B and 7-methoxybenanomicinone (Rt' s 22. 8, 16 .9, 8.7 and 6.8 minutes, respectively) were detected.
Antibiotics in the culture filtrate were adsorbed on a column of Diaion HP-20 (Mitsubishi Chemical
Ind.) and eluted with aq MeOHand MeOHto separate the benanomicin A fraction from the benanomicin B fraction.1} The benanomicin A fraction contained also dexylosylbenanomicin A and 2'-demethylbenanomicin A. It was purified by reverse-phase column chromatography and by precipitation in an acidic solution, and each antibiotic was isolated in a pure state. The benanomicin B fraction contained dexylosylbenanomicin B and 7-methoxybenanomicinone and was purified by repetition of Sephadex LH-20 (Pharmacia Fine Chemicals) column chromatography to isolate each antibiotic in a pure state.
Structures
Structures of dexylosylbenanomicin A, 2'-demethylbenanomicin A and 7-methoxybenanomicinone were determined by comparison of their XHand 13C NMRspectra with those of benanomicin A, as shown in Tables  1 and 2. The trans-diQqu&torial  relation  of 5-H and 6-H (5S,6S or 5R,6R) in 7-methoxybenanomicinone was shown by the coupling constants (3/s_h,c-45 3^5-H,c-6a> 3^5-H,c-i4b? 3^6-H,c-4a> 3^6-h,c-7 and 3^6-H,c-i4a)°f l°ng range selective proton decoupling (LSPD) experiment ( Fig. 2 ) and JSt6 value of XH NMR( Table 1) . The stereochemistry of the alanine moiety in dexylosylbenanomicin A or 7-methoxybenanomicinone was confirmed as the^-configuration by HPTLCpre-coated plate CHIR (E. Merck) of its hydrolysis product. The presence of the glycine moiety in 2'-demethylbenanomicin Awas also confirmed by the acid hydrolysis.
Dexylosylbenanomicin A was derived from benanomicin A by periodate oxidation and reductive cleavage, and the stereochemistry of this material was identical with that of the same compoundisolated from the fermentation. Dexylosylbenanomicin B was also identical with the dexylosyl product obtained by acid hydrolysis of benanomicin B,1 2) in all respects. Recently, Bristol-Myers scientists isolated pradimicins D and E as the glycine analogues of pradimicins Aand C.7) As their structures are 2'-demethyl-iV-methyl and 2'-demethyl derivatives of benanomicin B, respectively, four minor benanomicins described in this paper are recognized as new microbial products.
Biological Activities The antifungal activity of dexylosylbenanomicins A and B was similar or greater than that of benanomicins A and B against Candida, Saccharomyces and Cryptococcus, but these compounds had Tables 1 and 2 .
HPLCAnalysis of Antibiotics in Culture Filtrate A sample solution (5fi\) was applied to a Shimadzu HPLCsystem consisting of Shimadzu LC-6A pump, Shimadzu SPD-2A UVdetector and Chromatopack R-C1B integrator. The reversed phase Cosmosil C18 column (4.6i.d. x 150mm, particle size 5/mi, Nacalai Tesque Inc.) and pre-column (4.6i.d. x 50mm, particle size lO^m) were used and operated at 40°C and a flow rate of 1.0ml/minute, using a 1 : 1 mixture of 0.5% KH2PO4aq solution (pH 5.8) and MeOHas a mobile phase. UVabsorbance was monitored at 280nm.
The antibiotics in the culture filtrate1* (l ml) were adsorbed on a small column of Diaion HP-20 (3ml). After being washed with H2O (10ml), the column was eluted with 50% aq Me2CO(6ml). The eluate was concentrated to dryness and the residue was dissolved in H2O(1 ml). Separation of the antibiotics in the solution by HPLC is shown in Fig. 1A . Benanomicin B and dexylosylbenanomicin B (each 100 /ig/ml) were clearly separated as shown in Fig. IB .
Crude Precipitates of Antibiotics from Culture Filtrate1}
The antibiotics in the filtrate (250 liters, pH 6.0) which was obtained by fermentation of Actinomadura sp. MH193-16F4in a 570-liter fermenter1* were adsorbed on a column of Diaion HP-20 (15 liters). After the column was washed with H2O(100 liters) and 50% aq MeOH(45 liters), the antibiotics were eluted with 70% aq MeOH(45 liters) and then MeOH(90 liters). The eluate was divided into three fractions; I (benanomicin A fraction, 53 liters), II (benanomicin A fraction, 38 liters) and III (benanomicin B fraction, 27 liters). Each fraction was concentrated to 3.0, 2.0 and 1.5 liters and adjusted to pH 3.5 to give crude precipitates; I (152g), II (81 g) and III (99g), respectively.
Isolation of Dexylosylbenanomicin A Crude precipitate I (1 50 g) described above, was dissolved in DMF(600 ml) and kept in a H2O-saturated desiccator at room temperature for 3 days to obtain a crystalline precipitate (29g) of the DMFsolvate containing mostly benanomicin A. The mother liquour of the solvate was concentrated to obtain a brownish crude powder (130g). A solution of the crude powder (5g) in H2O (200ml) adjusted to pH 9 with I n NaOHwas re-adjusted to pH 2.5 with 1 n HC1to yield a precipitate. The precipitate was dissolved in H2O (100 ml) adjusted to pH 7 and purified by reverse-phase column chromatography (1.0 liter, Cosmosil 75C18-OPN, Nacalai Tesque, Inc.) developed with 1%MeOH. The eluate which showed Rt 22.7minutes by HPLC, was adjusted to pH 3.5 with 1 n HC1and a reddish precipitate of pure dexylosylbenanomicin A (345mg) was obtained. MP >200°C, FD-MS mlz 696 (M+ 1)+. Pure benanomicin A (2.1 g) was also obtained from the eluate with 5% MeOH(Rt 24.5 minutes).
Isolation of 2/-Demethylbenanomicin A The DMFsolvate (1 g) described above, was dissolved in H2O (40ml) adjusted to pH 7.5 with I n NaOHand purified by reverse-phase column chromatography ( Crude precipitate III (1 g) described above, was dissolved in DMF(40ml) and chromatographed on a column of Sephadex LH-20 (1.0 liter) developed with DMF.The eluate was collected in 6 -ml fractions. Fractions 64~72 were combined and concentrated to obtain a crude powder (657mg). The powder was dissolved in a mixture ofMeOH(100ml) and 1 n HC1(1 ml), and the solution was concentrated to dryness. A solution of the residue in DMSO(3 ml) was added dropwise into chloroform (200ml) and then stirred for 20minutes. Pure benanomicin B hydrochloride (565 mg) which showed Rt 8.2 minutes by HPLC, was precipitated. The filtrate was concentrated to 5 ml and chromatographed on a column of Sephadex LH-20 (600 ml) which was developed with MeOH.The eluate showing Rt 6.8 minutes by HPLCwas concentrated to obtain a reddish powder of pure 7-methoxybenanomicinone (38.5 mg). MP>220°C, FD-MSm/z 579 (M+).
Isolation of Dexylosylbenanomicin B
From the Sephadex LH-20 chromatography of crude precipitate III described above, fractions 75~80 were combinedand concentrated to obtain a crude powder of dexylosylbenanomicin B DMFsolvate (68.5mg). A solution of the crude powder in H2Oadjusted to pH 9.0 with 1 n NaOHwas re-adjusted to pH 5.5 with 1 n HC1to give a precipitate. The precipitate was purified by column chromatography on Sephadex LH-20 (700ml) which was developed with 80% aq MeOH.The eluate showing Rt 8.7 minutes by HPLCwas concentrated to yield a reddish powder of pure dexylosylbenanomicin B hydrochloride (52.3 mg). It was identical with the hydrolysis product derived from benanomicin B.1 2) Synthesis of Dexylosylbenanomicin A Sodium metaperiodate (2.71 g) was added to a solution of benanomicin A (1.05g) in 0.02n NaOH (127 ml) and the solution was stirred at room temperature for 40 minutes. After addition ofethylene glycol (0.8 ml), the solution was stirred for a further 15 minutes and passed through a column of Diaion HP-20 (800ml). After being washed with H2O(2 liters), the column was eluted with 40% aq Me2COand the eluate was collected in 100-ml fractions. Fractions 7~12 were combined and concentrated to 20ml. The concentrate was adjusted to pH 2.5 with 0. 1 n HC1to obtain a reddish precipitate of the diformyl compound (905mg). To a solution of this compound (200mg) in 0.01 n NaOH(25ml), NaBH4(15mg) was added and the solution was stirred at room temperature for 20 minutes. After being adjusted to pH 3.0 with 0.1 n HC1and stirred for 30 minutes, the solution was re-adjusted to pH 7.5 with 0.1 n NaOHand passed through a column of Diaion HP-20 (100ml). After being washed with H2O(200ml), the column was eluted with 30%aq Me2COand the eluate was collected in 5-ml fractions. Fractions 12~28 were combined and concentrated to give a reddish powder (159mg). The powder was dissolved in DMSO(2ml) and chromatographed on a Sephadex LH-20 column (1.0 liter) developed with MeOH.The eluate was collected in 7-ml fractions and fractions 52~64 were combined and concentrated to 5 ml. To the concentrate, 0.01 n HC1 (5ml) was added to yield a reddish precipitate of dexylosylbenanomicin A (52.6mg) which was, identical with material isolated directly from the fermentation.
Determination of p-Alanine in Dexylosylbenanomicin A and 7-Methoxybenanomicinone Dexylosylbenanomicin A (5mg) in 6n HC1 (20ml) was heated at 110°C in a sealed tube for 15 hours. The reaction mixture was filtered and the filtrate was concentrated to dryness. An aq solution (0.5 ml) of the residue was passed through a column of Diaion HP-20 (1 ml) and the column was washed with H2O (1.5ml). The effluent and washings were combined and charged on a column of Diaion PK-208 (H+, 1 ml, Mitsubishi Chemical Ind.). After the column was washed with H2O(3 ml), an amino acid was eluted with 0.5 n NH4OH(2ml). The eluate was concentrated to dryness and the residue was dissolved in H2O(0.1 ml). By similar treatment of 7-methoxybenanomicinone, D-alanine was also detected.
